Literature DB >> 18476063

Ethical issues associated with routine screening and prophylaxis for group B streptococcus in pregnancy.

M K Yancey1, A Schuchat, P Duff.   

Abstract

An increased awareness of the impact of group B streptococcus (GBS) infection on neonatal outcome has prompted several seemingly discordant committee recommendations. Intrapartum antibiotics are effective in reducing the risk of neonatal morbidity when administered to a colonized woman who has a clinical condition that places her neonate at high risk for early-onset sepsis. However, less is known about the efficacy of prophylactic antibiotics in the colonized woman who does not have obvious risk factors. Some authorities have suggested that providers refrain from administering intrapartum antibiotics to colonized women who do not have any of these risk factors, primarily due to concerns about potential adverse reactions, selection of resistant pathogens, and cost-effectiveness. These recommendations may conflict with the desires of an informed woman who weighs the real, albeit low, risk for serious neonatal disease against the lower perceived risk of adverse maternal sequelae from allergic reactions to the antimicrobial agents. Selective prophylaxis for GBS disease that is limited to the colonized parturient with risk factors has the potential for creating conflict because maternal beneficence-based obligations of the physician may be at odds with maternal autonomy-based obligations. We believe that, given all currently available information, providers have a moral obligation to discuss GBS screening and treatment issues with patients. The potential for conflict between patient and physician at the time of delivery can be minimized through the use of preventive ethics, allowing patients to develop advance directives regarding intrapartum management within the confines of reasonable and cost-effective care. Until a consensus is reached among experts, the most prudent approach would be to address such issues proactively and individualize care based upon the overall estimation and anticipation of risk as well as the patient's specific desires.

Entities:  

Year:  1996        PMID: 18476063      PMCID: PMC2364458          DOI: 10.1155/S1064744996000099

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  22 in total

1.  Anaphylactic reaction to ampicillin and severe complication in the fetus.

Authors:  K Heim; A Alge; C Marth
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

2.  Prenatal informed consent for sonogram: an indication for obstetric ultrasonography.

Authors:  F A Chervenak; L B McCullough; J L Chervenak
Journal:  Am J Obstet Gynecol       Date:  1989-10       Impact factor: 8.661

3.  Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock.

Authors:  O Idsoe; T Guthe; R R Willcox; A L de Weck
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

4.  Strategies for chemoprophylaxis of GBS early-onset infections.

Authors:  K M Boyer; S P Gotoff
Journal:  Antibiot Chemother (1971)       Date:  1985

5.  Single-dose penicillin prophylaxis against neonatal group B streptococcal infections. A controlled trial in 18,738 newborn infants.

Authors:  J D Siegel; G H McCracken; N Threlkeld; B Milvenan; C R Rosenfeld
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245

6.  Peripartum infection associated with vaginal group B streptococcal colonization.

Authors:  M K Yancey; P Duff; P Clark; T Kurtzer; B H Frentzen; P Kubilis
Journal:  Obstet Gynecol       Date:  1994-11       Impact factor: 7.661

7.  Prenatal screening for group B Streptococcus. I. Impact of antepartum screening on antenatal prophylaxis and intrapartum care.

Authors:  B M Mercer; R D Ramsey; B M Sibai
Journal:  Am J Obstet Gynecol       Date:  1995-09       Impact factor: 8.661

8.  Early-onset group B streptococcal sepsis: a current assessment.

Authors:  L E Weisman; B J Stoll; D F Cruess; R T Hall; G B Merenstein; V G Hemming; G W Fischer
Journal:  J Pediatr       Date:  1992-09       Impact factor: 4.406

9.  Clinical guides to preventing ethical conflicts between pregnant women and their physicians.

Authors:  F A Chervenak; L B McCullough
Journal:  Am J Obstet Gynecol       Date:  1990-02       Impact factor: 8.661

10.  Penicillin in infants weighing two kilograms or less with early-onset Group B streptococcal disease.

Authors:  S P Pyati; R S Pildes; N M Jacobs; R S Ramamurthy; T F Yeh; D S Raval; L D Lilien; P Amma; W I Metzger
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

View more
  1 in total

1.  Intrapartum PCR assay versus antepartum culture for assessment of vaginal carriage of group B streptococci in a Danish cohort at birth.

Authors:  Mohammed Rohi Khalil; Niels Uldbjerg; Poul Bak Thorsen; Jens Kjølseth Møller
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.